Breast Cancer Clinical Trial
Official title:
A Comparison of Ultrasound-assisted Paravertebral Block and General Anesthesia for Outpatient Breast Cancer Surgery, a Prospective Randomized Trial
The purpose of this project is to determine if there is a difference between paravertebral block and general anesthesia in terms of time to discharge from the Post-Anesthesia Care Unit and pain level in patients undergoing outpatient breast cancer surgery.
The optimal anesthetic technique for breast cancer surgery allows for good postoperative
pain relief and rapid discharge. Breast cancer surgery with potential axillary dissection is
often performed under general anesthesia due to the potential for poor analgesia with local
anesthetic infiltration at the surgical site alone. General anesthesia can be associated
with increased post-operative pain, nausea, and delayed discharge when compared to regional
anesthesia for breast and other types of procedures (1,2).
The paravertebral block is a technique that has been used perioperatively for breast (3,4),
thoracic (5), abdominal (6), and hernia surgeries (7). It has also been used for pain
control after rib fractures and penetrating trauma (8,9). The paravertebral block is
performed by injecting local anesthetic above or below the transverse processes of the
vertebral bodies where the spinal nerve roots emerge from the intervertebral foramina. The
most common technique is to insert a needle 2.5 centimeters lateral to the spinous process
at each level and "walk off" the transverse process. Injections at one or multiple levels
block the somatic and sympathetic innervation to these dermatomes (10).
Rare complications of thoracic paravertebral blocks include epidural spread, intrathecal
injection, and Horner's Syndrome (1,11,12). One of the most feared complications of the
traditional technique is pleural puncture, which has an incidence of 0.64% to 6.7% in the
published literature (3,11,13).
Ultrasound guidance in regional anesthesia is gaining widespread popularity. This technology
provides visualization of key anatomic structures and has been shown to decrease block
placement and onset times (14,15) and improve patient comfort (15). Ultrasound-guided blocks
are associated with success rates of greater than 90% (15,16). In the thoracic region,
ultrasound can be used to identify the vertebral transverse processes, as well as the ribs
and the pleura of the lungs (17). In this way, pleural puncture can be avoided during
paravertebral block placement.
To date there have been no published prospective, randomized trials comparing the multiple
injection thoracic paravertebral technique using ultrasound guidance to general anesthesia
in breast cancer surgery patients.
Our hypothesis is that paravertebral block anesthesia will result in shorter Post Anesthesia
Care Unit (PACU) stays and decreased Visual Analog Scale (VAS) scores when compared to
general anesthesia in patients undergoing breast cancer surgery. Secondary endpoints will
include the need for postoperative opioids and the presence of nausea and/or vomiting.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |